Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why did he die?

Damian A Laber1

  • 1Department of Medicine, Division of Medical Oncology and Hematology, University of Louisville, J.G. Brown Cancer Center, Louisville, Kentucky, USA. damianla@ulh.org

Cancer Investigation
|July 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Recurrent Venous Thromboembolism on Anticoagulation.

Journal of clinical medicine·2026
Same author

Direct Oral Anticoagulants in Budd-Chiari Syndrome.

European journal of haematology·2024
Same author

Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera.

Journal of clinical medicine·2024
Same author

Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trial.

Contemporary clinical trials communications·2024
Same author

Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study.

European journal of haematology·2023
Same author

Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis.

Journal of Cancer·2023
Same journal

Analysis of Second Primary Tumours in Cutaneous Lymphoma Populations.

Cancer investigation·2026
Same journal

The Heterogeneity of B Cells Potentially Contributes to Metastasis of Clear Cell Renal Cell Carcinomas.

Cancer investigation·2026
Same journal

The Association Between Lymphocyte-Monocyte Ratio, Tumor-Infiltrating Lymphocytes, and Tumor-Associated Macrophages with 3-Year Progression-Free Survival in Advanced Local Stage Nasopharyngeal Cancer Patients.

Cancer investigation·2026
Same journal

<i>In Vivo</i> Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.

Cancer investigation·2026
Same journal

Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments.

Cancer investigation·2026
Same journal

Adrenal Carcinoma Laterality is of Limited Clinical Significance: A National Perspective.

Cancer investigation·2026
See all related articles

The exact causes of cancer patient mortality remain unclear, prompting a discussion on declining postmortem examination rates. Further research into cancer cell lethality is crucial for developing effective cancer therapies.

Area of Science:

  • Oncology
  • Pathology

Background:

  • The precise mechanisms by which cancer leads to patient death are not fully understood.
  • There is a concerning trend of decreasing postmortem examination rates among cancer patients, limiting crucial data acquisition.

Purpose of the Study:

  • To highlight the critical need for understanding cancer cell-induced mortality.
  • To advocate for increased research into the underlying causes of cancer patient death.
  • To emphasize the importance of postmortem examinations in cancer research.

Main Methods:

  • Discussion of the significance of postmortem examinations in cancer research.
  • Review of current understanding of cancer cell lethality.
  • Pledge to support future research initiatives.

Related Experiment Videos

Main Results:

  • The exact reasons for cancer patient mortality are not definitively established.
  • Declining rates of postmortem examinations hinder comprehensive understanding.
  • Elucidating cancer cell mechanisms is vital for therapeutic advancement.

Conclusions:

  • Further investigation into cancer patient mortality is essential.
  • Understanding cancer cell death pathways can inform novel therapeutic strategies.
  • Support for research into the causes of cancer death is paramount.